Annual Accounts Payable
$4.63 M
+$2.56 M+123.12%
31 December 2023
Summary:
NRx Pharmaceuticals annual accounts payable is currently $4.63 million, with the most recent change of +$2.56 million (+123.12%) on 31 December 2023. During the last 3 years, it has risen by +$1.48 million (+46.91%). NRXPW annual accounts payable is now at all-time high.NRXPW Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$4.87 M
-$149.00 K-2.97%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly accounts payable is currently $4.87 million, with the most recent change of -$149.00 thousand (-2.97%) on 30 September 2024. Over the past year, it has increased by +$1.24 million (+34.01%). NRXPW quarterly accounts payable is now -22.37% below its all-time high of $6.27 million, reached on 30 June 2021.NRXPW Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.1% | +34.0% |
| 3 y3 years | +46.9% | -12.5% |
| 5 y5 years | - | +805.6% |
NRXPW Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +123.1% | -22.3% | +58.1% |
| 5 y | 5 years | at high | +644.2% | -22.4% | >+9999.0% |
| alltime | all time | at high | +644.2% | -22.4% | >+9999.0% |
NRx Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.87 M(-3.0%) |
| June 2024 | - | $5.01 M(-20.0%) |
| Mar 2024 | - | $6.26 M(+35.3%) |
| Dec 2023 | $4.63 M(+123.1%) | $4.63 M(+27.6%) |
| Sept 2023 | - | $3.63 M(+18.0%) |
| Dec 2022 | $2.08 M(-43.7%) | - |
| June 2022 | - | $3.08 M(-28.6%) |
| Mar 2022 | - | $4.31 M(+16.9%) |
| Dec 2021 | $3.69 M | $3.69 M(-33.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $5.56 M(-11.3%) |
| June 2021 | - | $6.27 M(>+9900.0%) |
| Dec 2020 | $3.15 M(+406.6%) | $609.51(>+9900.0%) |
| Sept 2020 | - | $0.38(-100.0%) |
| June 2020 | - | $297.24 K(-5.1%) |
| Mar 2020 | - | $313.24 K(-49.7%) |
| Dec 2019 | $622.44 K | $622.44 K(+15.8%) |
| Sept 2019 | - | $537.31 K(+24.2%) |
| June 2019 | - | $432.45 K(-3.1%) |
| Mar 2019 | - | $446.37 K |
FAQ
- What is NRx Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual accounts payable year-on-year change?
- What is NRx Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly accounts payable year-on-year change?
What is NRx Pharmaceuticals annual accounts payable?
The current annual accounts payable of NRXPW is $4.63 M
What is the all time high annual accounts payable for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual accounts payable is $4.63 M
What is NRx Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, NRXPW annual accounts payable has changed by +$2.56 M (+123.12%)
What is NRx Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of NRXPW is $4.87 M
What is the all time high quarterly accounts payable for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly accounts payable is $6.27 M
What is NRx Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, NRXPW quarterly accounts payable has changed by +$1.24 M (+34.01%)